EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy
The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.
The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.